Source: International Congress 2016 – Human responses to exposure, including physiological and biomarker outcomes
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
Hans Peter Rihs (Bochum, Germany), Hans Peter Rihs, Irina Raiko, Jan Gleichenhagen, Ingrid Sander, Jens Kollmeier, Thomas Brüning, Georg Johnen. A polypeptide of the megakaryocyte potentiating factor is a potential biomarker in plasma for the detection of mesothelioma. Eur Respir J 2016; 48: Suppl. 60, 388

Member's Comments

No comment yet.

Related content which might interest you: Serum IL-33 as a diagnostic and prognostic marker in non- small cell lung cancer Source: International Congress 2014 – Pathology and prognostic factors of thoracic tumours Year: 2014 mRNA biomarker screening in pulmonary tumors showing neuroendocrine differentiation Source: Annual Congress 2013 –Prognostic factors and subtyping of lung cancer Year: 2013 Potential genetic markers for the early diagnosis of peripheral and metastatic lung cancer Source: International Congress 2015 – Cell biology of lung cancer and new biomarkers Year: 2015 Rhesus CE expression is an independent prognostic factor in non-small cell lung cancer Source: International Congress 2016 – Prognostic variables in lung cancer II Year: 2016 Metabolic modification as a potential therapeutics approach in lung cancer Source: Annual Congress 2013 –Systemic therapy of lung cancer and quality of life Year: 2013 MET genetic lesions in NSCLC are functional markers of early hematogenous spreading and radioresistance Source: International Congress 2015 – Biomarkers, immunology and molecular pathology of lung cancer Year: 2015 MET genetic lesion in pleural tumor of unknown primary origin. A preliminary report Source: International Congress 2015 – Emerging technologies for malignant pleural diseases management Year: 2015 Serum interleukin-10 levels as a prognostic factor in advanced non-small cell lung cancer patients Source: Annual Congress 2013 –Prognostic factors and subtyping of lung cancer Year: 2013 Expression of interleukin-18 and interleukin-18 receptor mRNA in lung tissue samples from non small lung cancer Source: International Congress 2015 – Cell biology of lung cancer and new biomarkers Year: 2015 Association of the endothelin-1 and endothelin A receptor genetic polymorphisms and non-small cell lung cancer in Taiwan Source: International Congress 2016 – Prognostic variables in lung cancer I Year: 2016 Interleukin 27 (IL27) as a novel therapeutic tool in lung cancer immune therapy Source: Annual Congress 2013 –Systemic therapy of lung cancer and quality of life Year: 2013 Significance of EGFR expression patterns in patients with non-small cell lung cancer – Evaluation on protein- and/or gene level? Source: International Congress 2014 – Pathology and prognostic factors of thoracic tumours Year: 2014 The diagnostic puzzle of ALK rearrangement in lung cancer. A novel intron related abnormality Source: Annual Congress 2013 –Biology and molecular pathology of lung cancer Year: 2013 Serum osteopontin as a prognostic marker in patients with lung cancer Source: International Congress 2015 – Lung cancer: prognostic factors and features of oncogene-driven tumours Year: 2015 PIWI proteins as prognostic markers in non small cell lung cancer Source: International Congress 2015 – Lung cancer: prognostic factors and features of oncogene-driven tumours Year: 2015 Proapoptotic effects of PAI-1 protein on lung and prostate cancer cells Source: Annual Congress 2013 –Basic research on lung cancer Year: 2013 Expression and clinical implications of the estrogen receptor β in lung adenocarcinoma Source: International Congress 2016 – Prognostic variables in lung cancer I Year: 2016 Early response detection in systemic lung cancer treatment using cell-free methylated SHOX2 (mSHOX2) plasma DNA Source: International Congress 2015 – Biomarkers, immunology and molecular pathology of lung cancer Year: 2015 Comprehensive evaluation of nuclear factor-κΒ expression patterns in non-small cell lung cancer Source: International Congress 2015 – Biomarkers, immunology and molecular pathology of lung cancer Year: 2015 Tumor cell-derived osteopontin promotes lung metastasis via both cell-autonomous and paracrine pathways Source: International Congress 2016 – Late-breaking translational research in lung cancer Year: 2016